CD274 and neoplasm: In addition, TAMs may result in enhanced expression of programmed cell death ligand 1 (PD-L1), PD-L2, CD80 and CD86 by tumor cells, which upon interaction with cognate receptors can dampen CD8 T-cell responses [9, 10].